NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Spring bank pharmaceuticals says begun dosing first patients in global phase 2 clinical program evaluating sb 9200 in hbv patients without cirrhosis. Says phase 2a study has an adaptive trial design that will enroll 80 chronically-infected hbv patients.   Source : reuters.com

news

As many as 2,839 bottles of anti-bacterial medicine Nitrofurantoin Oral Suspension manufactured by Sun Pharmaceutical Industries are being recalled in the US market on account of failed dissolution specifications. The ongoing nationwide voluntary recall by Nostrum Laboratories Inc for Nitrofurantoin Oral Suspension, usp, 25 mg/5 mL is a class II…

news

India said it is revising its drugs law to make it easier for companies to do business while ensuring the safety and efficacy of medicines, in Prime Minister Narendra Modi's latest move to encourage industry. Until last year, India was trying to tweak its archaic Drugs and Cosmetics Act of…

news

Lupin has received final approval from the US health regulator to market generic Voriconazole tablets as well as oral suspension for treatment of fungal infections in the American market. Company's US subsidiary Gavis Pharmaceuticals LLC has received final approvals to market "its Voriconazole tablets, 50 mg & 200 mg and…

news

The commerce ministry's decision on Monday to relax the norms for foreign direct investment in existing pharma companies or brownfield units has finally ended a six-year long uncertainty over regulations on mergers and acquisitions in the sector viewed as critical for supplies of affordable medicines. Multinational pharma companies or financial…

news

Wave Life Sciences receives orphan drug designation from FDA for its lead candidate designed to treat Huntington's Disease. On track to file investigational new drug (IND) application in late 2016.   Source : reuters.com

news

VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets, pleased to announce that it has received the approvals for Van-Fer tablets (NPN:80070021) and capsules (NPN:80070125). Van-Fer contains Ferrous Fumarate, an iron supplement indicated for the prevention and treatment of anemia and iron…

news

Alexza Pharmaceuticals, Inc. and Grupo Ferrer Internacional, S.A. announced the expiration of the tender offer (the "Offer") by Ferrer Pharma Inc., a wholly-owned indirect subsidiary of Ferrer ("Ferrer Pharma"), to purchase all of the outstanding shares of Alexza's common stock at a price (the "Offer Price") of $0.90 per share,…

news

Zydus Healthcare, a subsidiary of Cadila Healthcare, today said it has acquired two abbreviated new drug applications (ANDAs) from Teva Pharmaceutical in the US for an undisclosed sum. "Zydus has strengthened its US portfolio with the acquisition of two ANDAs from Teva that are being divested by Teva as a…

news

Kiadis Pharma appoints PCT as its contract manufacturing organization in the United States. Deal for manufacturing of cell therapy product for U.S. and canada clinical trial sites for phase 3 trial of Kiadis' product, Atir101.   Source : reuters.com